Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06027814 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

MHealth Incentivized Adherence Plus Patient Navigation

Study acronym: MIAPP
StatusCompleted
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial completed Study completion date changed from estimate of Sep 22, 2026 to Oct 13, 2025 · Eligibility criteria expanded, about 14 words · Secondary endpoints: details revised at 1 of 5 entries · 1 more Show 4 more changesShow less
    • Study completion date changed from estimate of Sep 22, 2026 to Oct 13, 2025
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 1 of 5 entries
    • Publications: details revised at 1 of 1 entry
  2. Results first posted: May 27, 2026 Secondary endpoints revised (5) · Primary endpoint revisedv7 Show 2 more changesShow less
    • Secondary endpoints revised (5)
    • Primary endpoint revised

    See this version in full on ClinicalTrials.gov ↗

  3. Primary completion date changed from estimate of Nov 2025 to Apr 14, 2025v6
  4. Trial status: Recruiting to Active, Not Recruiting Site details revisedv5 Show 1 more changeShow less
    • Site details revised
  5. Primary completion date: Nov 2024 to Nov 2025 Completion date: Sep 22, 2025 to Sep 22, 2026 · Site contact updatedv4 Show 2 more changesShow less
    • Completion date: Sep 22, 2025 to Sep 22, 2026
    • Site contact updated
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Jan 2024 to Jan 3, 2024v3 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Jan 2024 to Jan 3, 2024
  2. Start date: Sep 2023 to Jan 2024v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Polysubstance use involving opioids and methamphetamine is emerging as a new public health crisis. Patients with opioids and methamphetamine use often experience serious medical complications requiring hospitalization, which provides an opportunity to offer addiction treatment. Yet linkage to outpatient treatment post-discharge is suboptimal and methamphetamine exacerbates outcomes. The investigators propose to pilot test "MHealth Incentivized Adherence Plus Patient Navigation" (MIAPP) to promote treatment linkage and retention for patients with opioid use disorder (OUD) and methamphetamine use who initiate buprenorphine in the hospital. The investigators Aim is to perform a two-arm, pilot randomized clinical trial (n=40) comparing MIAPP + treatment-as-usual (TAU) versus TAU alone on outpatient medication for opioid use disorder (MOUD) linkage within 30 days (primary) and 90-day retention on medications (secondary) among hospitalized patients with OUD and methamphetamine use.
Trial Details
NCT Number NCT06027814
Lead Sponsor University of Washington
Collaborators: National Institute on Drug Abuse (NIDA)
Conditions Opioid Use Disorder, Medication Adherence, Polysubstance Drug Use (Indiscriminate Drug Use), Methamphetamine-dependence
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov